Search clinical trials for: PD-L1 Antibody
Total 10169 results
-
Chugai PharmaceuticalCompleted
-
Shenzhen Geno-Immune Medical InstituteEnrolling by invitationGlioblastoma Multiforme | Glioblastoma Multiforme of BrainChina
-
Shanghai Chest HospitalRecruitingNon-Small Cell Lung CancerChina
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
SUNHO（China）BioPharmaceutical CO., Ltd.RecruitingAdvanced Malignant TumorsChina
-
Klinikum EsslingenRecruitingCarcinoma, Non-Small-Cell LungGermany
-
Assuntina Sacco, M.D.PfizerTerminated
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Hutchison Medipharma LimitedRecruitingExtensive-Stage Small Cell Lung CancerChina
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Lee's Pharmaceutical LimitedEnrolling by invitationBiliary Tract CancerChina
-
Merck Sharp & Dohme LLCTerminatedNeoplasmUnited States, Canada, Israel
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
CellSight Technologies, Inc.Not yet recruitingAdvanced Non Small Cell Lung Cancer
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Stage IV | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Merck Sharp & Dohme LLCCompletedGastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingColorectal NeoplasmsUnited States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non Small Cell Lung CancerDenmark, United States, Argentina, Australia, Austria, Belgium, Brazil, Finland, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Poland, Russian Federation, Spain, Switzerland, Taiwan, Thailand
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Incyte CorporationTerminatedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, Bulgaria, Hungary, Taiwan, Ukraine
-
Kostas N.SyrigosCompleted
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co...UnknownSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentChina
-
Dragonboat Biopharmaceutical Company LimitedFudan UniversityRecruitingBladder Cancer | Renal Carcinoma | Advanced Penile CarcinomaChina
-
Merck Sharp & Dohme LLCActive, not recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CarcinomaPoland, Russian Federation, United States, Australia, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAdvanced Lung CarcinomaChina
-
Incyte CorporationZai Lab (Shanghai) Co., Ltd.Active, not recruitingMetastatic Squamous Non-Small Cell Lung Cancer | Metastatic Nonsquamous Non-Small Cell Lung CancerChina, Czechia, Russian Federation, Serbia, Malaysia, Vietnam, United States, Poland, Ukraine, Romania, Turkey, Brazil, Bulgaria, Georgia, Hungary, Philippines, South Africa
-
Immunobrain CheckpointNational Institute on Aging (NIA); Alzheimer's AssociationRecruitingAlzheimer's DiseaseIsrael, United Kingdom, Netherlands
-
ARCAGY/ GINECO GROUPAstraZenecaActive, not recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingRecurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Cairo UniversityAbdelhamid, Bassant Mohamed, M.D.; Mohamed, Ahmed A., M.D.; Hala Mostafa Gomaa; Mohamed saeid AliCompletedUltrasound Guided L1,L2 Paravertebral BlockEgypt
-
Qilu Hospital of Shandong UniversityWithdrawn
-
Bio-Thera SolutionsSun Yat-sen UniversityRecruiting
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
University Medical Center GroningenRecruiting
-
Shanghai Zhongshan HospitalRecruitingAdvanced Gastric CancerChina
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Guru SonpavdePfizer; Hoosier Cancer Research NetworkWithdrawnKidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney CarcinomaUnited States
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsFrance, Germany, Spain, United Kingdom
-
Sohag UniversityRecruitingPancreatic AdenocarcinomaEgypt
-
Incyte CorporationWithdrawn